Joshua A. Kazam

Insider Reports History

Entity: Individual
Location: 689 5 Th Avenue, 12 Th Floor, New York, NY
Signature: /s/ Allison Frisbee, Attorney-in-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Joshua A. Kazam:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Allogene Therapeutics, Inc.	Director	Stock Option (Right to buy)	191K			Jun 5, 2024	Direct
Kronos Bio, Inc.	Director	Stock Option (Right to Buy)	34K			Jun 25, 2024	Direct
TS Innovation Acquisitions Corp.	Former Director	Class A Common Stock	30K			Jun 4, 2021	Direct
TS Innovation Acquisitions Corp.	Former Director	Class B common stock	0			Jun 4, 2021	Direct

Showing 1 to 4 of 4 entries

Insider Reports Filed by Joshua A. Kazam

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
KRON	Kronos Bio, Inc.	Jun 25, 2024	1	$0	4	Jun 26, 2024	Director
ALLO	Allogene Therapeutics, Inc.	Jun 5, 2024	1	$0	4	Jun 7, 2024	Director
KRON	Kronos Bio, Inc.	Jun 22, 2023	1	$0	4	Jun 26, 2023	Director
ALLO	Allogene Therapeutics, Inc.	Jun 13, 2023	1	$0	4	Jun 15, 2023	Director
KRON	Kronos Bio, Inc.	Jun 22, 2022	1	$0	4	Jun 29, 2022	Director
ALLO	Allogene Therapeutics, Inc.	Jun 15, 2022	1	$0	4	Jun 17, 2022	Director
ALLO	Allogene Therapeutics, Inc.	Mar 7, 2022	2	$0	4	Mar 9, 2022	Director
ALLO	Allogene Therapeutics, Inc.	Jan 12, 2022	1	$189K	4	Jan 14, 2022	Director
SCRM	Screaming Eagle Acquisition Corp.	Jan 5, 2022	0	$0	3	Jan 6, 2022	Director
KRON	Kronos Bio, Inc.	Jun 22, 2021	1	$0	4	Jun 23, 2021	Director
ALLO	Allogene Therapeutics, Inc.	Jun 10, 2021	2	$0	4	Jun 11, 2021	Director
LTCH	TS Innovation Acquisitions Corp.	Jun 4, 2021	2	$0	4	Jun 7, 2021	Former Director
KRON	Kronos Bio, Inc.	Mar 7, 2021	2	$0	4	Mar 9, 2022	Director